Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer.
Saved in:
| Title: | Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer. |
|---|---|
| Authors: | Ghisoni E; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland; Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Benedetti F; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Minasyan A; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Desbuisson M; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Cunnea P; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0HS, UK., Grimm AJ; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Fahr N; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Capt C; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Rayroux N; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., De Carlo F; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Gulhan DC; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland; Massachusetts General Hospital Cancer Center and Harvard Medical School Department of Medicine, Boston, MA, USA., Dagher J; Unit of Translational Oncopathology, Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland., Barras D; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Morotti M; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Marín-Jiménez JA; Cancer Immunotherapy Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Chap BS; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Santoro T; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Spagnol G; Department of Women and Children's Health, Unit of Gynecology and Obstetrics, University of Padua, Padua, Italy., Fleury M; Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Fortis K; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Dorier J; Bioinformatics Competence Center, University of Lausanne, Lausanne, Switzerland., Townsend MK; Division of Oncological Sciences, OHSU Knight Cancer Institute, Portland, OR, USA., Tissot S; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Rusakiewicz S; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Ferreira HJ; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Kraemer AI; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Bassani-Stenberg M; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland., Swisher EM; Department of Obstetrics/Gynecology, University of Washington, Seattle, WA, USA., Kandalaft LA; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland; Center of Experimental Therapeutics, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Mastroyannis SA; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Montone KT; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Powell DJ Jr; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Banerjee S; The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK., Terry KL; Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Tworoger SS; Division of Oncological Sciences, OHSU Knight Cancer Institute, Portland, OR, USA., Pittet MJ; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Tanyi JL; Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA 19104, USA., Coukos G; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland; Immuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland., Merritt MA; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, NSW, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Fotopoulou C; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London W12 0HS, UK., Conejo-Garcia JR; Department of Integrative Immunobiology, Duke School of Medicine, Durham, NC 27707, USA., Laniti DD; Department of Oncology, Lausanne University Hospital; Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne (UNIL); Agora Cancer Research Center, Lausanne, Switzerland. Electronic address: denarda.dangaj@chuv.ch. |
| Source: | Cancer cell [Cancer Cell] 2025 Aug 11; Vol. 43 (8), pp. 1568-1586.e10. Date of Electronic Publication: 2025 Jul 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
